A Study of Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT04100330 · WITHDRAWN
Trial details
- NCT number
- NCT04100330
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2020-03-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.